CXR's collaborative approach, proprietary models and cutting edge expertise have helped customers of all sizes solve issues relating to the selection of drug candidates or safety of compounds. CXR's services and partnering models are flexible – it provides Drug Development Solutions and Investigative Toxicology services and expertise on a fee-for-service basis.
At the core of Innova’s business are Lightning-Link® and InnovaCoat™, innovative technologies that simplify antibody, protein and oligonucleotide labeling for use in R&D applications, drug discovery and the development of diagnostic kits. The easy to use, one step procedure allows scientists to label an antibody with 30 seconds hands on time, saving both time and money.
Oxford Expression Technologies
OET is a biotech company in the field of recombinant protein expression, and a recognized centre of excellence for baculovirus expression. We produce both recombinant proteins and more complex structures such as Virus-Like Particles (VLP) for use in research and therapeutics. We provide products, services and consultancy to a variety of partners in industry and academia.
XenoGesis Ltd. is a laboratory-based contract research organisation (CRO) specialised in preclinical drug metabolism & pharmacokinetics (DMPK), quantitative bioanalysis and expert interpretation. The core XenoGesis team has an enviable track record of delivery in drug discovery, combining state-of-the-art in vitro, in vivo and bioanalytical capabilities with expert pharmacokinetic/ pharmacodynamic (PK/PD) data interpretation services